<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Joe Ponzio&#039;s F Wall Street &#187; RATE</title>
	<atom:link href="http://www.fwallstreet.com/symbol/rate/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.fwallstreet.com</link>
	<description>Value Investing Blog</description>
	<lastBuildDate>Fri, 10 Jun 2011 21:28:28 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Amylin III &#8211; Seven months (and much heartbreak) later</title>
		<link>http://www.fwallstreet.com/article/120-amylin-iii-seven-months-and-much-heartbreak-later/</link>
		<comments>http://www.fwallstreet.com/article/120-amylin-iii-seven-months-and-much-heartbreak-later/#comments</comments>
		<pubDate>Wed, 05 Mar 2008 05:44:00 +0000</pubDate>
		<dc:creator>Joe Ponzio</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Companies Analyzed]]></category>

		<guid isPermaLink="false">http://www.fwallstreet.com/article/120-amylin-iii-seven-months-and-much-heartbreak-later</guid>
		<description><![CDATA[In late July, I posted an analysis of Amylin Pharmaceuticals (AMLN) that was not exactly a favorite of Michael&#8217;s. I figured that my response belonged in a post rather than in the comments because it was more of a &#8220;noise vs. news&#8221; debate, and Michael responded in turn with some&#8230;]]></description>
			<content:encoded><![CDATA[<p>In late July, I posted <a title="an analysis of Amylin Pharmaceuticals" href="/article/31-waiting-to-exhale-amylin-pharmaceuticals">an analysis of Amylin Pharmaceuticals</a> (AMLN) that was <a title="not exactly a favorite of Michael's" href="/article/31-waiting-to-exhale-amylin-pharmaceuticals#comment-91">not exactly a favorite of Michael&#8217;s</a>. I figured that <a title="my response belonged in a post" href="/article/32-amylin-ii-excuse-the-sarcasm">my response belonged in a post</a> rather than in the comments because it was more of a &#8220;noise vs. news&#8221; debate, and <a title="Michael responded in turn" href="/article/32-amylin-ii-excuse-the-sarcasm#comment-95">Michael responded in turn</a> with some clarification. (It&#8217;s not easy to debate online because (a) space is limited and (b) 90% or so of communication &#8211; the nonverbal &#8211; is non-existent so we must rely on that unreliable 10% &#8211; the words.)</p>
<p>The whole discussion revolved around two simple concepts. I believed that Amylin was like every other company out there &#8211; that it had an intrinsic value and that, although I couldn&#8217;t peg the value, it was almost certainly less than $6 billion (the then market capitalization). Michael took a different side &#8211; Amylin was worth considerably more than $6 billion, and that smaller investors (operating within their own risk tolerance) should look to buy companies they know (Michael is a pharmacist by profession) <em>before</em> those companies make their billions.</p>
<p>We both approached the company rationally; still, we can&#8217;t fight the law &#8211; price follows value. Know the value and you&#8217;ll know what price to pay. Not sure of the value? Decision time: Move on? Or, leave your fate in the hands of the traders?</p>
<h2><span id="more-120"></span>How to make money in stocks.</h2>
<p>I&#8217;ve said it before &#8211; there are a million and one ways to make and lose money in the stock markets. You can be a value investor, a technical trader, a speculator, or anywhere in between. You can put your money in index funds; you can invest in mutual fund managers that follow a technique or style you like, but which you do not have time to implement. You can play penny stocks or follow the Dogs of the Dow.</p>
<p>No matter how you invest, you should study and learn new ways, new methods, and new strategies so that you can constantly reinforce (or improve) your own skills. It&#8217;s the reason that Buffett knows so much about technical trading, even though he never uses it in stocks; it&#8217;s why the Oracle can speak about anything and everything, <strong>even though he focuses on doing just a few things really well.</strong></p>
<h2>Your Sphere of Competence should be bigger than your Sphere of Confidence.</h2>
<p>We can all get a touch of guru-itis &#8211; that psychological carcinogen that burns money faster than we can make it. When things are working and we&#8217;re making money, we begin to get comfortable. Things seem so easy that we believe that we are always right and that everything we touch will make money. I got a touch of the fever back in late December and <strong>I lost money splashing around in a pool I should not have been in.</strong></p>
<p>Chuckling as I placed the trade, wy confidence was through the roof; my competence was not.</p>
<p>I don&#8217;t know about you, but I welcome these little episodes because I learn from them &#8211; not just in the traditional &#8220;learn from your mistakes&#8221; but in the actual &#8220;I remember every bonehead move I&#8217;ve ever made that lost money or that cost me an opportunity to make money.&#8221; (It helps that my business partner, Mike, constantly busts my chops, too. <em>Hey Joe, did you see Bankrate (RATE) today? $42.50.</em>)</p>
<p><strong>For example:</strong> I bought RATE around $11 late in 2004, and then sold it when Wall Street disliked an earnings call and pushed the price down. I second-guessed my decision, got scared, dumped out around $9.50, and never bought in again. <em>Oops</em>. (Actually, it was many thousand shares, so this was a very large, six figure <em>oops</em>.)</p>
<p>The point is simple: You have a sphere of competence in which you should be looking for opportunities. <strong>The hardest part about investing is watching companies you don&#8217;t own run up like crazy.</strong> I would love to have bought Mosaic (MOS) in 2006 at $14 and change, and watch my investment grow ten-fold in a year. But I don&#8217;t have a very good grasp on phosphate, potash, and animal feed.</p>
<h2>The sphere inside the sphere.</h2>
<p>I do, however, have a small sphere of competence in technology. I&#8217;m not crazy about the sector as a whole; still, I do see some opportunities from time to time. (I don&#8217;t avoid it just because Buffett avoids it.) <strong>Inside that sphere of competence is a much smaller sphere &#8211; my confidence.</strong> I&#8217;ve owned very few &#8220;tech&#8221; companies in the past, but my sphere-inside-my-sphere allowed me to buy Google around $100 and Apple between $38 and $85, and sell them both around $185.</p>
<p>Was I wrong to sell Google around $185? No. At that point, the price shot out of my sphere of confidence, and I never saw it enter again. I would have welcomed the other $550 a share of growth; I would not have been happy hoping for it had the stock price tanked.</p>
<h2>Price follows value, regardless of what your spheres tell you.</h2>
<p>Money can be made in the stock market when you approach a company from the <em>buy before they&#8217;ve made their billions</em> perspective. It has served a number of early investors in Apple and Google, and will continue to work in the future. There is a flip side to that coin &#8211; if you merely speculate on companies that you <em>think</em> will make billions (and these are a plenty in biotech, just like in tech and the dot com boom/bust), you will end up with a ton of losers as well.</p>
<p>Price follows value &#8211; and Amylin is down some 50% in seven months. What is the value of Amylin? I can&#8217;t say for certain, but I do know that it is the value of the cash that can be taken out of the business during its remaining life. Until now, <strong>Amylin was worth nothing more than its break-up value.</strong> Why? Let me explain.</p>
<h2>Cash taken out versus cash put in</h2>
<p>My uncle, a small business owner, said something very interesting to me yesterday:</p>
<blockquote><p>When you have to start putting cash into your business, it&#8217;s time to get out of your business.</p></blockquote>
<p>If your business is not self-sufficient, it&#8217;s worthless. I&#8217;m not talking about &#8220;in a single quarter&#8221; or &#8220;in a particular year or two&#8221;, but in general &#8211; over the long-term, through good and bad times, taken as a whole.</p>
<p>Amylin has been increasing revenues. It has also been selling stock and borrowing money. (Surprisingly, this means very little to many investors.) At some point, it may become self-sufficient and mature to become a business with a value greater than its break-up value. Still, so long as it is <em>not</em> self-sufficient, so long as it is borrowing money and diluting its per share break-up value, <strong>it is worthless from a business-owner&#8217;s perspective</strong>.</p>
<h2>You can bend the rule, but you can&#8217;t break it</h2>
<p>The stock market is a place to buy and sell businesses, even if many people make their living or lose their retirements speculating on <a title="what the Greater Fool will do" href="http://en.wikipedia.org/wiki/Bigger_fool_theory" target="blank">what the Greater Fool will do</a>. Over the long-term, the price of a stock follows the value of the business &#8211; it&#8217;s the rule that has governed the markets for as long as we&#8217;ve had markets, and you can&#8217;t break it. In the short-term, price follows the daily trend of what the buyers and sellers are doing. In the short-term, price does not necessarily follow value.</p>
<p>Lest you think I consider seven months to be the long-term, I don&#8217;t. Over the past five years, Amylin has bent the rule &#8211; trading from as low as $13.73 to as high as $53.25. Today, it&#8217;s at $24 and change, down almost 50% over the past seven months.</p>
<p>What should Amylin be trading at? With no earnings (and hence, no P/E ratio) to guide some investors, and with no ability to generate cash and no idea of how well it will do so in the future to guide business investors, Amylin&#8217;s price is entirely in the hands of the traders. If you can&#8217;t put a value on Amylin, there is no way to know whether or not you are overpaying or underpaying, and no way to judge your potential returns. <strong>You can not possibly have any expectations,</strong> just hope.</p>
<p>Whether Amylin will be up or down 50% over the next seven months, I don&#8217;t know. If it &#8220;keeps doing what it&#8217;s doing,&#8221; I&#8217;ll know that it will be priced well above its value (currently, its break-up value) and I&#8217;ll know that its price is not guided by any business principals or valuations, but by the traders.</p>
<p>No matter which way it goes, I won&#8217;t be surprised at the results. Neither should you.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.fwallstreet.com/article/120-amylin-iii-seven-months-and-much-heartbreak-later/feed/</wfw:commentRss>
		<slash:comments>9</slash:comments>
		</item>
		<item>
		<title>How To Find Companies Worth Analyzing</title>
		<link>http://www.fwallstreet.com/article/58-how-to-find-companies-worth-analyzing/</link>
		<comments>http://www.fwallstreet.com/article/58-how-to-find-companies-worth-analyzing/#comments</comments>
		<pubDate>Thu, 13 Sep 2007 04:27:00 +0000</pubDate>
		<dc:creator>Joe Ponzio</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[How to Search for Opportunities]]></category>

		<guid isPermaLink="false">http://www.fwallstreet.com/article/58-how-to-find-companies-worth-analyzing</guid>
		<description><![CDATA[Analyzing companies is fairly straightforward. Finding companies to analyze is a different ballgame. In the U.S. alone, there are more than 10,000 publicly traded companies. With the power of the internet, we can now invest worldwide-bringing the number of available investment options to staggering proportions. Let&#8217;s narrow it down a&#8230;]]></description>
			<content:encoded><![CDATA[<p>Analyzing companies is fairly straightforward. Finding companies to analyze is a different ballgame. In the U.S. alone, there are more than 10,000 publicly traded companies. With the power of the internet, we can now invest worldwide-bringing the number of available investment options to staggering proportions.</p>
<p>Let&#8217;s narrow it down a bit.<br />
<span id="more-58"></span><br />
<a title="Hemel asked" href="/article/55-do-the-math-in-your-head#comment-243">Hemel asked</a>,</p>
<blockquote><p>One of my challenges has been creating screens to filter stocks. What items would you consider for this? I can understand basic things like industry, size of company etc but what about other tech and non-tech indicators?</p></blockquote>
<p>I also got an e-mail asking,</p>
<blockquote><p>One question I had was how do you pick which stocks to do extra [due diligence] and run the value numbers. Do you do a scan or look into up or down sectors? Do you just pick a company out of the air and run the numbers?</p></blockquote>
<h2>The Non-Method To My Madness</h2>
<p>I have a number of different ways depending on how I feel that day.</p>
<p>One day, I&#8217;ll look at my <a title="Morningstar" href="http://www.morningstar.com/" target="blank">Morningstar</a> list of all companies with positive free cash flow for the last ten years-about 450 companies. Sometimes I&#8217;ll head over to the <a title="MSN free stock screener" href="http://moneycentral.msn.com/investor/controls/finderpro.asp" target="blank">MSN free stock screener</a> and scan for companies with 15%+ growth in earnings for the past few years. I also like to look at the companies whose products I use: Research in Motion for my Blackberry, HP for my computer monitor, Dell for my computer, etc. or stores in which my wife or I shop (she can single-handedly increase a company&#8217;s owner earnings!)</p>
<p>I also check the NYSE and NASDAQ sites daily to see which companies have had the biggest daily drops. When a company plummets quickly, it&#8217;s usually because of bad Wall Street news. I like to check those stocks out because they may still be wonderful businesses that the stock market is overreacting to.</p>
<p>I don&#8217;t have a specific method to my madness. I try to find opportunity wherever I can.</p>
<h2>Use The Tools They Give You</h2>
<p>When running free stock screeners, you&#8217;ll have to play Wall Street&#8217;s game to generate an initial list of targets. By that I mean that you&#8217;ll have to use their criteria for searching: growing earnings, high returns on equity and invested capital, etc.</p>
<p>I generally start by setting all of the growth rates to 15% or greater. After I get through that list, I&#8217;ll run it again with 10% growth rates.</p>
<p>If using the Morningstar premium screener, scan for companies with positive free cash flow for at least 6 or 7 years-preferably ten years.</p>
<h2>The Big Losers</h2>
<p>When a stock drops 5%, 10%, 20% or more, it may be that Wall Street is overreacting to news that will otherwise not affect the future health of the company. A prime example (which I screwed up on) was Bankrate in 2004. I bought the company around $11 a share.</p>
<p>A few days later, near the end of October, Wall Street overreacted to a less-than-stellar earnings report and pushed the stock down 16% to as low as $9.20. Stupid me-I panicked with them, convincing myself that they knew something I didn&#8217;t. I sold for a one week 10% loss. I was thinking like a gambler, not a business owner.</p>
<p>Two years later, it was a $50 stock. (<em>As an aside, that was the very last time I ever listened to Wall Street</em>.)</p>
<h2>Find Opportunities Everywhere</h2>
<p>Unfortunately there is no secret list or magic screener that will identify the best businesses. To drive this home, we turn to investment stud Peter Lynch:</p>
<blockquote><p>The person that turns over the most rocks wins the game.</p></blockquote>
<p>Of course, don&#8217;t expect to run a screen, analyze a business, and run out and buy one today. Sometimes there are great companies on sale; sometimes you&#8217;ll sit on the sidelines, accumulating cash and waiting weeks, months, or even a year or two for an opportunity. As Buffett says,</p>
<blockquote><p>You do things when the opportunities come along. I&#8217;ve had periods in my life when I&#8217;ve had a bundle of ideas come along, and I&#8217;ve had long dry spells. If I get an idea next week, I&#8217;ll do something. If not, I won&#8217;t do a damn thing.</p></blockquote>
<p>Remember: Finding a business worth buying is much more difficult than the act of buying. Turn over rocks-you&#8217;ll see a lot of grubs, worms, and dirt. Still, the very next rock may be sitting on a box of gold.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.fwallstreet.com/article/58-how-to-find-companies-worth-analyzing/feed/</wfw:commentRss>
		<slash:comments>15</slash:comments>
		</item>
	</channel>
</rss>

